Which statement about adverse effects of CGRP antagonists is NOT true?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

Which statement about adverse effects of CGRP antagonists is NOT true?

Explanation:
CGRP antagonists have a generally favorable safety profile with adverse effects that are usually mild and non-hematologic. Taste changes (dysgeusia) have been reported with this class, and there are notes of vasospastic phenomena like new-onset Raynaud’s in some patients due to reduced CGRP-mediated vasodilation. In contrast, significant hematologic toxicity is not a characteristic feature of CGRP antagonists, so the statement claiming they cause major hematologic toxicity is not true.

CGRP antagonists have a generally favorable safety profile with adverse effects that are usually mild and non-hematologic. Taste changes (dysgeusia) have been reported with this class, and there are notes of vasospastic phenomena like new-onset Raynaud’s in some patients due to reduced CGRP-mediated vasodilation. In contrast, significant hematologic toxicity is not a characteristic feature of CGRP antagonists, so the statement claiming they cause major hematologic toxicity is not true.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy